ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1909–1920 of 2250 project topics
Endometrial Cancer Clonal Architecture and Evolution Mapping Platform
A computational platform that reconstructs tumor clonal composition and evolutionary dynamics from multi-region or single-cell sequencing data in endometrial cancers. Business models include software licensing to research institutions, collaboration fees with biopharma companies studying resistance mechanisms, and academic partnerships.
Genomics of Endometrial Cancer Click to view more details →
Endometrial Cancer Driver Gene Annotation and Reporting Marketplace
A curated digital marketplace and SaaS platform providing expert-annotated endometrial cancer driver mutations, therapeutic implications, and updated clinical evidence summaries. Revenue streams include subscription tiers for individual researchers, institutional licenses, integration APIs for EHR systems, and white-label solutions for genomic laboratories.
Genomics of Endometrial Cancer Click to view more details →
Glioblastoma WGS Multi-Omic Profiling
Applying WGS, RNA-seq, and methylation profiling for comprehensive GBM characterization including EGFR, PTEN, and IDH status.
Genomics of Brain Tumors Click to view more details →
IDH Mutant Glioma Epigenome Analysis
Characterizing 2-HG driven hypermethylation and CIMP phenotype in IDH mutant glioma using WGBS and array methylation.
Genomics of Brain Tumors Click to view more details →
Pediatric High-Grade Glioma H3 Histone Mutations
Profiling H3K27M and H3G34R/V mutations and their epigenomic consequences in pediatric high-grade glioma using ChIP-seq.
Genomics of Brain Tumors Click to view more details →
Brain Tumor Single Cell Transcriptome Analysis
Characterizing malignant cell states and tumor microenvironment composition in glioma using scRNA-seq for understanding cellular heterogeneity.
Genomics of Brain Tumors Click to view more details →
Meningioma Driver Mutation Commercial Testing Platform
A clinical diagnostic SaaS platform that identifies recurrent meningioma driver mutations (TRAF7, KLF4, NF2) through targeted sequencing and reports actionable variants for treatment selection. This enables hospitals and oncology centers to offer precision medicine services with recurring revenue from per-test fees and laboratory partnerships.
Genomics of Brain Tumors Click to view more details →
Medulloblastoma Subgroup Classification AI Software Tool
An artificial intelligence-powered tool that classifies medulloblastomas into molecular subgroups (WNT, SHH, Group 3, Group 4) using genomic and epigenomic data to guide therapy stratification. This product generates B2B2C revenue through licensing agreements with diagnostic laboratories and pediatric oncology centers worldwide.
Genomics of Brain Tumors Click to view more details →
Brain Metastasis Tumor Origin Detection Genomics Service
A commercial NGS-based service that determines primary tumor origin in brain metastases through comparative genomic analysis and mutation signature matching across cancer types. This addresses a critical clinical need and creates recurring revenue from oncology practices requiring diagnostic confirmation for treatment decisions.
Genomics of Brain Tumors Click to view more details →
Ependymoma Methylation Profiling Risk Stratification Platform
A cloud-based bioinformatics platform that performs DNA methylation profiling to stratify ependymomas into prognostic risk groups and treatment recommendations using proprietary algorithms. The platform monetizes through subscription licensing to pediatric cancer centers and enables premium tier services for real-time clinical reporting.
Genomics of Brain Tumors Click to view more details →
Brain Tumor Copy Number Variation Commercial Analysis Suite
An enterprise software suite that detects and interprets copy number variations in brain tumors to identify therapeutic targets and predict chemotherapy resistance patterns. This generates revenue through annual software licenses, data integration services, and partnerships with pharmaceutical companies conducting biomarker-driven trials.
Genomics of Brain Tumors Click to view more details →
Pituitary Adenoma Germline Predisposition Screening Platform
A commercial genetic testing platform that identifies germline predisposition mutations in familial pituitary adenoma syndrome cases (AIP, PRKAR1A, MEN1 genes) with clinical reporting. This opens new revenue streams through genetic counseling partnerships, family screening programs, and insurance billing for hereditary cancer risk assessment.
Genomics of Brain Tumors Click to view more details →